Where Can You Inject the Mounjaro Pen?

The three sites the prescriber will talk you through

When your Mounjaro pen arrives (tracked by DPD, in a plain unbranded box, cold-packed from our GPhC-registered pharmacy) the first practical question most people have is exactly where it goes. The licensed answer is one of three areas: the abdomen (belly), the front and outer part of the thigh, or the outer region of the upper arm.

The abdomen is the site most people start with. Aim for the area around the navel, but stay at least 5 cm away from it and avoid the belt line. The fatty tissue just beneath the skin there absorbs the medicine reliably and is easy to reach on your own. You can read more about abdomen-specific technique on our detailed injection site guidance page.

The thigh is a good alternative if you find the abdomen uncomfortable. Use the front or outer surface of either thigh, roughly the middle third between knee and hip. It is accessible without an assistant and gives a consistent fatty layer for most people. There is further detail on injecting Mounjaro into the leg if you would like to explore that site first.

The upper arm (specifically the fatty tissue of the outer, lower portion) is the third option. Most people find this easier with some assistance, though it is possible alone with practice. Our arm injection guide walks through the positioning in more detail. The NHS tirzepatide patient page confirms all three sites as appropriate for subcutaneous administration. NHS guidance on tirzepatide is a reliable first reference alongside your own Patient Information Leaflet.

Why rotating the site each week matters more than which site you pick

The decision about which site to use on any given week is less important than the habit of not using the same spot twice in a row. Repeated injections into an identical point can cause lipohypertrophy (a thickening or lumpiness of the fatty tissue) and that can slow or uneven out medicine absorption. Rotating weekly, and varying the precise spot within each site, keeps the tissue healthy.

A simple system that works for many people: left thigh one week, abdomen the next, right thigh the week after, then back to the abdomen, or whatever sequence you settle on with your prescriber. The key is keeping a mental note, or a brief log, so no single patch is overloaded. If you notice any skin change at a site, avoid that area and mention it at your next clinical review.

The Mounjaro injection overview covers the full sequence of steps including skin preparation. Using a fresh alcohol swab before each injection, then letting the skin dry before pressing the pen in, is standard practice. Our alcohol swabs are available if you need to restock between pens.

What to avoid, and when to get medical help

Regardless of which site you choose, there are places the pen should never go. Do not inject into a vein or muscle, Mounjaro is designed for subcutaneous (under the skin) delivery only, and intramuscular injection changes how the medicine is absorbed. Avoid skin that is currently bruised, scarred, tattooed over damaged tissue, or showing an active skin condition such as eczema or psoriasis at that exact spot.

Most injection-site reactions (mild redness, a small weal, temporary itching) settle within a day or two and do not usually need treatment. If a reaction persists, spreads, or you notice hard nodules forming, contact your prescriber. A question our prescribers hear fairly often is whether a reaction at the site means switching medicines altogether; in most cases the answer is simply adjusting the rotation pattern, but that judgement belongs to a clinician rather than a self-assessment.

If you experience symptoms beyond the injection site after your dose (particularly severe or persistent stomach pain that radiates to your back, with or without vomiting) seek prompt medical attention. The MHRA's January 2026 Drug Safety Update for GLP-1 medicines highlighted acute pancreatitis as a known but uncommon serious risk, and those symptoms warrant urgent clinical review rather than waiting for your next scheduled call. You can also report any suspected side effect through the MHRA Yellow Card scheme.

How your dose and site choice may change as treatment progresses

Mounjaro treatment typically begins at the 2.5 mg strength (a dose chosen to let your system adjust) and is stepped up by the prescriber over time. As the dose increases, some people find their GI response shifts, and the injection site can occasionally influence tolerability at the margins, though the evidence for this is anecdotal rather than established in trials. If you notice a pattern worth discussing, note it and raise it at your next review.

The process your prescriber follows at each dose increase includes reviewing how the previous pen has been tolerated, not just looking at the weight reading. That is one reason our prescribers ask for evidence before approving a step up: it is clinical oversight, not paperwork. If you are curious about how the Mounjaro pen mechanism works, or want context on the cost of ongoing treatment, both are worth reading alongside this guidance. And if you have not yet started treatment, our weight-loss treatment overview sets out the full picture.